| Caroline Haven Humphreys, | |
|
757 Westwood Plz, Emergency Medicine, Los Angeles, CA 90095-7419 | |
| (310) 794-0785 | |
| Not Available |
| Full Name | Caroline Haven Humphreys |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 757 Westwood Plz, Los Angeles, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013449065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A160956 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highland Hospital | Oakland, CA | Hospital |
| Alameda Hospital | Alameda, CA | Hospital |
| Lac/olive View-ucla Medical Center | Sylmar, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alameda Health System | 3779494521 | 504 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
| Entity Name | Alameda Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740332931 PECOS PAC ID: 3779494521 Enrollment ID: O20031110000764 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
| Entity Name | County Of Santa Clara |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
| Entity Name | Shasta Regional Emergency Medical Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679007140 PECOS PAC ID: 0941587588 Enrollment ID: O20170508001882 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caroline Haven Humphreys, 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: (310) 301-8707 | Caroline Haven Humphreys, 757 Westwood Plz, Emergency Medicine, Los Angeles, CA 90095-7419 Ph: (310) 794-0785 |
News Archive
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
› Verified 3 days ago
Dr. Tiffany Hackett, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd., Los Angeles, CA 90048 Phone: 310-967-1884 Fax: 310-967-1744 | |
Brennen J. Beatty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Matthew S. Berry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Phillip Gruber, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 N State St, Los Angeles, CA 90033 Phone: 323-226-6667 | |
Daniel Weingrow, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 757 Westwood Plz, Los Angeles, CA 90095 Phone: 310-825-2111 | |
Brian Truong, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 Westwood Blvd, Suite 300, Los Angeles, CA 90095 Phone: 310-794-0585 | |
Emily Michele Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-9922 |